Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 161-170 of 283 for Lung cancer

Edit search filters
  1. A Study Comparing X-396 (Ensartinib) To Crizotinib In Patients With ALK Positive Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  2. Trial Of Measles Virotherapy In Combination With Nivolumab In Patients With Metastatic Non-Small Cell Lung Cancer

    Rochester, MN

  3. VX15/2503 In Combination With Avelumab In Advanced Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Anetumab Ravtansine And Atezolizumab In Treating Participants With Advanced Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Deuterated Phenanthrene Tetraol In Smokers Who Are At High Risk For Lung Cancer

    Rochester, MN

  6. Linsitinib Or Topotecan Hydrochloride In Treating Patients With Relapsed Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  7. Study Of Pembrolizumab (MK-3475) In Participants With Relapsed Or Refractory Primary Mediastinal Large B-cell Lymphoma Or Relapsed Or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)

    Rochester, MN

  8. Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  9. Ruxolitinib In Combination With Pemetrexed/Cisplatin In Non Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study Of AT13387 In Patients With Non-Small Cell Lung Cancer (NSCLC) Alone And In Combination With Crizotinib

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer